Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03302416Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by University of Pittsburgh. Primary endpoint: [C-11]NOP-1A Volume of Distribution Expressed Relative to Total Plasma Concentration. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03302416.